Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Telix Pharmaceuticals Limited - American Depositary Shares (NQ:TLX)

7.560 -0.070 (-0.92%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 9, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	99,037
Open	7.710
Bid (Size)	7.520 (100)
Ask (Size)	7.800 (200)
Prev. Close	7.630
Today's Range	7.520 - 7.710
52wk Range	7.380 - 30.36
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

TELIX FINAL CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Urgently Reminds Telix Pharmaceuticals Limited Stockholders to Contact the Firm Regarding Their Rights

Today 11:57 EST

From Bragar Eagel & Squire

Via GlobeNewswire

FINAL DEADLINE ALERT: Faruqi & Faruqi Reminds Telix Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 9, 2026

Today 10:10 EST

From Faruqi & Faruqi, LLP

Via Business Wire

Performance

YTD	-0.8%	-0.8%
1 Month	-21.4%	-21.4%
3 Month	-25.1%	-25.1%
6 Month	-53.0%	-53.0%
1 Year	-50.7%	-50.7%

More News

TLX Deadline Tomorrow: Rosen Law Firm Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important January 9 Deadline in Securities Class Action First Filed by the Firm – TLX

January 08, 2026

From The Rosen Law Firm, P.A.

Via Business Wire

UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals

January 08, 2026

From Faruqi & Faruqi LLP

Via GlobeNewswire

Deadline Soon: Telix Pharmaceuticals Limited (TLX) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

January 08, 2026

From The Law Offices of Frank R. Cruz

Via Business Wire

TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm

January 08, 2026

From Schall Law

Via GlobeNewswire

Telix to Present Pipeline and Commercial Portfolio Overview at J.P. Morgan Healthcare Conference

January 08, 2026

From Telix Pharmaceuticals Limited

Via GlobeNewswire

FRIDAY DEADLINE: Berger Montague Advises Telix Pharmaceuticals Ltd. (NASDAQ: TLX) Investors to Inquire About a Securities Fraud Class Action by January 9, 2026

January 07, 2026

From Berger Montague

Via GlobeNewswire

TLX DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important January 9 Deadline in Securities Class Action First Filed by the Firm – TLX

January 06, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

TELIX URGENT CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Telix Pharmaceuticals Limited Stockholders to Contact the Firm Regarding Their Rights Before January 9th

January 05, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm

January 05, 2026

From Schall Law

Via GlobeNewswire

UPCOMING DEADLINE: Faruqi & Faruqi Reminds Telix Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 9, 2026

January 02, 2026

From Faruqi & Faruqi LLP

Via GlobeNewswire

TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm

January 01, 2026

From Schall Law

Via GlobeNewswire

TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm

December 29, 2025

From Schall Law

Via GlobeNewswire

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals

December 26, 2025

From Faruqi & Faruqi LLP

Via GlobeNewswire

TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm

December 26, 2025

From Schall Law

Via GlobeNewswire

TLX DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – TLX

December 23, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm

December 22, 2025

From Schall Law

Via GlobeNewswire

Precision Medicine Portfolio Update: Illuccix China Phase 3 Study, TLX101-CDx and TLX250-CDx FDA Resubmissions

December 21, 2025

From Telix Pharmaceuticals Limited

Via GlobeNewswire

SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Telix Pharmaceuticals

December 21, 2025

From Faruqi & Faruqi, LLP

Via Business Wire

TLX INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals

December 19, 2025

From Faruqi & Faruqi LLP

Via GlobeNewswire

TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm

December 18, 2025

From Schall Law

Via GlobeNewswire

Robbins LLP Reminds Telix Pharmaceuticals Ltd. Stockholders About the January 9, 2026 Lead Plaintiff Deadline – Contact Us Today for Information About the TLX Class Action

December 15, 2025

From Robbins LLP

Via Business Wire

TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm

December 15, 2025

From Schall Law

Via GlobeNewswire

TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm

December 12, 2025

From Schall Law

Via GlobeNewswire

Frequently Asked Questions

Is Telix Pharmaceuticals Limited - American Depositary Shares publicly traded?

Yes, Telix Pharmaceuticals Limited - American Depositary Shares is publicly traded.

What exchange does Telix Pharmaceuticals Limited - American Depositary Shares trade on?

Telix Pharmaceuticals Limited - American Depositary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Telix Pharmaceuticals Limited - American Depositary Shares?

The ticker symbol for Telix Pharmaceuticals Limited - American Depositary Shares is TLX on the Nasdaq Stock Market

What is the current price of Telix Pharmaceuticals Limited - American Depositary Shares?

The current price of Telix Pharmaceuticals Limited - American Depositary Shares is 7.560

When was Telix Pharmaceuticals Limited - American Depositary Shares last traded?

The last trade of Telix Pharmaceuticals Limited - American Depositary Shares was at 01/09/26 04:00 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.